ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.
Samer A Srour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.